Actos

actosActos is a medication produced by Takeda Pharmaceuticals as a product to treat Type 2 Diabetes. The chances of contracting bladder cancer are extremely high for Actos users, however, and the FDA has issued warnings. Learn more about the Actos class action lawsuit.

ACTOS

Actos is a brand named medication produced by Takeda Pharmaceuticals. This medication was produced to treat Type 2 Diabetes and was formerly believed to be a highly safe and effective treatment for the illness. In fact, Actos was produced to be a much safer treatment option as opposed to the previously used medication Avandia. It was not until recently that the problems associated with Actos began to surface. In light of these problems, a settlement suit has started to take place. Actos was put on the market in 2010, and it was immediately prescribed to millions of patients.

At this time, the FDA has not yet banned the use of Actos, which is the brand name of the drug piogiltazone. However, the drug still is under evaluation and the Food and Drug Administration has issued a statement requiring the makers of the drug and all pharmacies to issue warnings along with each prescription of the drug. The FDA, at this time, feels that the warning is enough since the positive effects of the medication are still outweighing the negative effects. In other countries, namely Germany and France, the medication has been pulled from the market completely because of the negative side effects.

Would you like to discuss your Actos case with John Foy?

Overall, Actos did not show many symptoms or problems for patients. It was not until patients had been taking the medication for their Type 2 Diabetes for more than a year that problems began to exhibit. Just what symptom was so bad to cause a recall? More than one study has shown the same thing. Users who take Actos for more than one year continuously have an increased chance of developing the highly dangerous and often fatal bladder cancer. In fact, it is not just an increased risk. It is a severely increased risk. Patients have a 40% higher chance of developing the cancer.

At this time, a Actos class action lawsuit is being formed against Takeda Pharmaceuticals. It has yet to be determined how much each individual will receive in compensation, but there is a very good possibility that individuals who do contract bladder cancer will receive a much higher settlement amount than those who do not become ill.

If you have been taking Actos for a significant amount of time, then you may be entitled to compensation. Do not take risks and make sure you get the money you deserve. Call John Foy today, at (404) 879-7518 to get you a fair compensation or to learn more about pharmaceutical injury cases we have handled in the past.

By at .